Skip to main content

Genetics disease risk

Genetic, environmental factors in disease risk, new insights found




Environmental factors may play a larger role in disease risk than previously thought, overshadowing genetic contributions, a study by researchers at Penn State College of Medicine reveals.

Published in the journal Nature Communications, the research shows that lifestyle and environmental factors, such as air pollution, can significantly influence disease risk, offering more opportunities for mitigation.

“We’re trying to disentangle how much genetics and environment influences the development of disease,” said Bibo Jiang, assistant professor of public health sciences.

The team used a novel spatial mixed linear effect model, combining genetics and geolocation data, to analyse disease risks.

Co-senior author Dajiang Liu emphasised the importance of separating environmental influences from genetic factors, “If we can tease apart these shared environments, what’s remaining could more accurately reflect genetic heritability of disease.”

Using data from IBM MarketScan and environmental data, the researchers re-evaluated the genetic contributions to various diseases.

For example, the genetic risk of type 2 diabetes was recalibrated from 37.7 per cent to 28.4 per cent, highlighting a greater role for environmental factors. Similarly, the genetic contribution to obesity risk decreased from 53.1 per cent to 46.3 per cent.

The study also distinguished the effects of specific pollutants, such as PM2.5 and NO2, on health conditions. NO2 was found to directly influence conditions like high cholesterol and diabetes, whereas PM2.5 impacted lung function and sleep disorders.

This research suggests that understanding the balance between genetic and environmental factors can enhance disease prevention strategies, particularly in precision medicine.

Genetic disorders, hereditary diseases, DNA mutations, gene therapy, genetic testing, chromosomal abnormalities, inherited conditions, genetic predisposition, genomics, personalized medicine, rare diseases, familial risk, genetic counseling, autosomal recessive, autosomal dominant, carrier screening, molecular genetics, gene editing, epigenetics, genetic markers.

#GeneticDisorders #HereditaryDiseases #DNAMutations #GeneTherapy #GeneticTesting #ChromosomalAbnormalities #InheritedConditions #GeneticPredisposition #Genomics #PersonalizedMedicine #RareDiseases #FamilialRisk #GeneticCounseling #AutosomalRecessive #AutosomalDominant #CarrierScreening #MolecularGenetics #GeneEditing #Epigenetics #GeneticMarkers

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: x-i.me/gennom1
Award registration: x-i.me/genreg2
Member Nomination: x-i.me/genmember
Member Registration: x-i.me/genreg1
For Enquiries: genetics@healthcarek.com


Get Connected Here
---------------------------------
---------------------------------

Pinterest: x-i.me/genpt
Twitter: x-i.me/gentw
Facebook: x-i.me/genfb
Instagram: x-i.me/genin
Youtube: x-i.me/genyt

Comments

Popular posts from this blog

Genetics role in ovarian cancer

The Medical Minute: Genetics play big role in ovarian cancer In 2024, about 19,680 women in the United States will receive a new diagnosis of ovarian cancer and 12,740 women will die from the disease, said Dr. Shaina Bruce , a gynecologic oncologist at Penn State Cancer Institute . The median age of all patients who develop ovarian cancer is 63. Historically, women at increased risk for ovarian cancer are recommended to have their fallopian tubes and ovaries removed when they have completed having children. Taking that step to protect themselves comes at a heavy price ― surgical menopause. But Bruce said medical science is catching up with ovarian cancer. Studies could lead to new methods for preventative care and the surgery needed to lower risk may be easier than it once was. Below, during Gynecologic Cancer Awareness Month, Bruce discusses the disease and why acting to reduce your risk is worth it. What’s the connection between heredity and ovarian cancer? About 25% of all cases of ...

Migration in Population Genetics

  Migration in Population Genetics Migration in population genetics refers to the movement of individuals-and therefore their genes -between different populations of the same species. This gene flow alters allele frequencies, increasing genetic diversity within populations while reducing genetic differences between them. Migration can counteract the effects of genetic drift and inbreeding , introduce new alleles , and influence evolutionary processes such as adaptation and natural selection. The rate, direction, and scale of migration play a crucial role in shaping population structure, evolutionary potential, and long-term species survival, especially in fragmented habitats or changing environments. Migration, Population Genetics, Gene Flow, Allele Frequency, Genetic Diversity, Evolution, Genetic Variation, Population Structure, Adaptation, Biodiversity #PopulationGenetics #Migration #GeneFlow #GeneticDiversity #EvolutionaryBiology #AlleleFrequency #NaturalSelection #GeneticD...

Chromosomal Abnormalities

  Chromosomal Abnormalities Chromosome abnormalities refer to structural or numerical changes in chromosomes that can disrupt normal genetic function, leading to developmental disorders, congenital abnormalities, and various genetic diseases. These abnormalities may arise from errors in cell division, such as nondisjunction or chromosomal breakage, resulting in conditions like Down syndrome , Turner syndrome, Klinefelter syndrome , and various deletion or duplication syndromes. Understanding chromosome abnormalities is essential for genetic counseling, prenatal diagnosis, disease risk assessment, and research in cytogenetics and molecular genetics. Chromosome abnormalities, chromosomal disorders, chromosomal mutations, aneuploidy, structural chromosome abnormalities, nondisjunction, deletion syndrome, duplication syndrome , translocation, inversion, cytogenetics, karyotyping, prenatal diagnosis , genetic testing, genomic instability, Down syndrome, Turner syndrome, Klinefelter syn...